Variable |
Total |
Percentage |
p- value |
Duration of Catheterization 1-7 8-14 >14 |
29 60 54 |
20.27 41.95 37.76 |
0.025 Significant |
Number of attempts 1 2 3 |
15 95 33 |
10.48 66.43 23.07 |
0.015 Significant
|
Vein catheterized Subclavian
vein Internal
jugular vein Umbilical
vein |
68 57 18 |
47.55 39.86 12.58 |
0.023 Significant
|
Organisms isolated | Number of isolates in catheter colonization | Number of isolates in CRBSI |
Klebsiellaspp | 0 | 4 |
Coagulase negative Staphylococcus (CONS) | 9 | 3 |
Staphylococcus aureus | 7 | 2 |
Pseudomonas aeruginosa | 2 | 3 |
Escherichia coli | 3 | 1 |
Acinetobacterbaumanii | 3 | - |
Enterococcus | 3 | - |
Citrobacterspp | 2 | |
Enterbacterspp | 1 | |
Proteus spp | 1 | |
Candida Spp | 4 | 1 |
Total | 45 | 14 |
Antimicrobials |
Klebsiellaspp
(n=14) |
Pseudomonas
aeruginosa (n=5) |
Escherichia
coli (n=4) |
AcinetobacterSpp (n=3) |
Others (n=4) |
Amikacin |
12
(85.71%) |
3(60%) |
2(50%) |
1(33.33%) |
2(50%) |
Gentamicin |
6(42.85%) |
2(40%) |
2(50%) |
1(33.33%) |
0 |
Ciprofloxacin |
4(28.57%) |
2(40%) |
1(25%) |
0 |
0 |
Ceftazidime |
3((21.42%) |
2(40%) |
3(75%) |
2(66.66%) |
3(75%) |
Ceftriaxone |
3(21.42%) |
3(40%) |
2(50%) |
1(33.33%) |
3(75%) |
Piperacillin
–Tazobactam |
12(85.71%) |
3(60%) |
3(75%) |
2(66.66%) |
4(100%) |
CeftazidimeSulbactam |
11(78.57%) |
2(40%) |
4(100%) |
1(33.33%) |
4(100%) |
Ceftriaxone- Sulbactam |
11(78.57%) |
2(40%) |
4(100%) |
2(66.66%) |
4(100%) |
Imipenem |
14(100%) |
4(80%) |
4(100%) |
2(66.66%) |
4(100%) |
Polymyxinn
B |
14(100%) |
5(100%) |
4(100%) |
3(100%) |
3(100%) |
Antimicrobials |
S.
aureus N=9 |
CONS N=12 |
ENTEROCOCCUS N=3 |
Amikacin |
6(66.66%) |
7(58.33%) |
3(100%) |
Gentamicin |
3(33.33%) |
2(16.66%) |
1(33.33%) |
Ciprofloxacin |
3(33.33%) |
2(16.66%) |
2(66.66%) |
Ampicillin |
1(11.11%) |
1(8.33%) |
1(33.33%) |
Cefoxitin |
7(77.77%) |
11(91.6%) |
3(100%) |
Erythromycin |
3(33.33%) |
5(41.66%) |
1(33.33%) |
Cephalexin |
2(22.22%) |
4(33.33%) |
1(33.33%) |
Linezolid |
8(88.88%) |
12(100%) |
3(100%) |
Vancomycin |
9(100%) |
12(100%) |
3(100%) |